Correvio Pharma Corp (CORV) Covered Calls

You can sell covered calls on Correvio Pharma Corp to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CORV (prices last updated Thu 4:16 PM ET):

Correvio Pharma Corp (CORV) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
3.08 -0.34 3.00 4.00 1.0M - 0.1B
Covered Calls For Correvio Pharma Corp (CORV)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Apr 18 2.5 0.60 3.40 -26.5% -333.5%
May 17 2.5 0.70 3.30 -24.2% -152.3%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

As of May 15, 2018, Cardiome Pharma Corp. was acquired by Cipher Pharmaceuticals Inc. Cardiome Pharma Corp., a specialty pharmaceutical company, provides various therapeutic products for patients and healthcare providers in Europe and internationally. It offers Brinavess (vernakalant IV) for the conversion of recent onset atrial fibrillation to sinus rhythm in adults; and Aggrastat (tirofiban HCl), a reversible GP IIb/IIIa inhibitor for use in acute coronary syndrome patients. The company also provides Esmocard and Esmocard Lyo (esmolol hydrochloride), a short-acting beta-blockers used to control rapid heart rate; Xydalba (dalbavancin), a semi-synthetic lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections; and Zevtera/Mabelio (ceftobiprole medocaril sodium), a cephalosporin antibiotic for the treatment of pneumonia. Its products also comprise Trevyent, a development stage drug/device combination product for the treatment of pulmonary arterial hypertension. Cardiome Pharma Corp. was founded in 1986 and is based in Mississauga, Canada